TATA India PHARMA & Healthcare Fund - G

NAV ₹30.6646 ↓ -0.01 (-0.03 %) as on 7 Jul 25

Table of Contents

Scheme Objective
NAV Price Chart
Returns
- Historical Returns
- Compounded Returns
Growth Of 10k Over Years
Holdings / Portfolio
All Plan & Options
Fund Manager Information
Custodians
Registrar & Transfer Agent (RTA)
Administrator Companies
Auditors

Scheme Objective

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund launched on 28 Dec 15. It is a fund with High risk and has given a CAGR return of 12.5% since its launch. Return for 2024 was 40.4% , 2023 was 36.6% and 2022 was -8% .

Below is the key information for TATA India Pharma & Healthcare Fund

NAV as on 7 Jul 25	₹30.6646 ↓ -0.01 (-0.03 %)
Net Assets (AUM) as on 31 May 2025	₹1,232 Cr.
Launch Date	28 Dec 2015
Category	Equity - Sectoral
Rating	Not Rated
Type	Open Ended Fund
Risk	High
AMC	Tata Asset Management Limited

Alpha Ratio	1.9
Expense Ratio	0.0 %
Sharpe Ratio	0.538
Information Ratio	0.74
Benchmark	Not Available
Min Investment	₹5,000
Min SIP Investment	₹150
Exit Load	0-3 Months (0.25%),3 Months and above(NIL)

NAV Price Chart

Returns

Annual Compounded Returns

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 7 Jul 25

Duration	Returns
1 Month	3.8%
3 Month	12.6%
6 Month	-3.3%
1 Year	12.8%
3 Year	24.8%
5 Year	22.4%
10 Year
15 Year
Since launch	12.5%

Historical Annual Returns

Historical performance (Yearly) on absolute basis

Year	Returns
2024	40.4%
2023	36.6%
2022	-8%
2021	19.1%
2020	64.4%
2019	5.5%
2018	-2.6%
2017	4.7%
2016	-14.7%

Growth of 10k Over Years

Date	Value
30 Jun 20	₹10,000
30 Jun 21	₹15,403
30 Jun 22	₹13,787
30 Jun 23	₹16,370
30 Jun 24	₹23,471
30 Jun 25	₹27,032

Asset Allocation

Asset Class	Value
Cash	9.16%
Equity	90.84%

Sector Allocation

Sector	Value
Health Care	88.47%
Basic Materials	2.37%

Top Securities Holdings / Portfolio

Holdings/Securities

Name	Global Industry	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Jan 16 \| SUNPHARMA	Drug Manufacturers - Specialty & Generic	12%	₹143 Cr	854,300
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 31 Dec 16 \| APOLLOHOSP	Medical Care Facilities	6%	₹77 Cr	111,255 ↑ 10,000
Cipla Ltd (Healthcare) Equity, Since 30 Apr 20 \| CIPLA	Drug Manufacturers - Specialty & Generic	6%	₹72 Cr	490,000
Aurobindo Pharma Ltd (Healthcare) Equity, Since 30 Apr 20 \| AUROPHARMA	Drug Manufacturers - Specialty & Generic	6%	₹71 Cr	615,100
Divi's Laboratories Ltd (Healthcare) Equity, Since 30 Sep 17 \| DIVISLAB	Drug Manufacturers - Specialty & Generic	6%	₹69 Cr	104,965
Fortis Healthcare Ltd (Healthcare) Equity, Since 31 Oct 20 \| FORTIS	Medical Care Facilities	5%	₹60 Cr	855,100
Lupin Ltd (Healthcare) Equity, Since 30 Nov 17 \| LUPIN	Drug Manufacturers - Specialty & Generic	5%	₹59 Cr	303,240
Aster DM Healthcare Ltd Ordinary Shares (Healthcare) Equity, Since 31 Dec 22 \| ASTERDM	Medical Care Facilities	4%	₹54 Cr	956,991
Wockhardt Ltd (Healthcare) Equity, Since 31 Mar 24 \| WOCKPHARMA	Drug Manufacturers - Specialty & Generic	3%	₹40 Cr	274,871
Dr Reddy's Laboratories Ltd (Healthcare) Equity, Since 31 Aug 18 \| DRREDDY	Drug Manufacturers - Specialty & Generic	3%	₹39 Cr	311,555

1 - 10 of 41

Ready to Invest?
Talk to our investment specialist

Fund Managers

Name	Since	Tenure
Meeta Shetty	9 Mar 21	4.23 Yr.
Rajat Srivastava	16 Sep 24	0.71 Yr.

Custodians

Company	Address
Deutsche Bank AG	Deutsche Bank AG,Kodak House, 22, D.N. Road,

Registrar & Transfer Agent

Computer Age Management Services Ltd
Address	New No.10, Old No.178,,Kodambakkam High Road,,Opp. Hotel Palmgrove,,Nungambakkam
FAX	91-44-28283610
Email	enq_L@camsonline.com

Administrator Companies

Company	Address
Tata Mutual Fund	1903, B-Wing, Parinee Crescenzo,,G-Block, Bandra Kurla Complex, Bandra East Mumbai 400051

Auditors

Company	Address
Deloitte Haskins & Sells LLP	12, Dr. Annie Besant Road, Opp. Shiv Sagar Estate,,Worli
M/s BSR & Co.	KPMG House, Kamala Mills Compound,448 Senapati Bapat Marg,Lower Parel

All Plan & Options

Fund and Plan	NAV	6 Month	1 Year	3 Year	5 Year
TATA India Pharma & Healthcare Fund Normal Dividend, Reinvestment	₹30.6646 ↓ -0.01	-3.34 %	12.79 %	24.82 %	22.44 %
TATA India Pharma & Healthcare Fund Normal Dividend, Payout	₹30.6646 ↓ -0.01	-3.34 %	12.79 %	24.82 %	22.44 %
TATA India Pharma & Healthcare Fund Growth	₹30.6646 ↓ -0.01	-3.34 %	12.79 %	24.82 %	22.44 %
Data as on 7 Jul 25

Disclaimer:
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data.

Shepard Technologies Pvt. Ltd : 1808, Solus, Hiranandani Estate, Thane, Maharashtra - 400607

AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153

Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing. Past performance is not indicative of future returns. Please consider your specific investment requirements before choosing a fund, or designing a portfolio that suits your needs.

Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.